Primary CNS Lymphoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Characterisation of TIM-3/Gal-9 Immune Checkpoints in Primary Central Nervous System Diffuse Large B Cell Lymphomas
Condition: Lymphoma, B-Cell Intervention: Sponsor: University Hospital, Montpellier Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2021 Category: Research Source Type: clinical trials